|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500111857 |
|
最近更新日期: Date of Last Refreshed on: |
2025-11-06 17:28:04 |
|
注册时间: Date of Registration: |
2025-11-06 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
老年人睡眠障碍与轻度认知障碍共病的双向关系: 潜在剖面与网络分析研究 |
|
Public title: |
Bidirectional Relationship Between Sleep Disorders and Mild Cognitive Impairment in Older Adults: Latent Profile and Network Analyses |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
老年人睡眠障碍与轻度认知障碍共病的双向关系: 潜在剖面与网络分析研究 |
|
Scientific title: |
Bidirectional Relationship Between Sleep Disorders and Mild Cognitive Impairment in Older Adults: Latent Profile and Network Analyses |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
吴艾静 |
研究负责人: |
赵珺瑜 |
|
Applicant: |
Wu Aijing |
Study leader: |
Zhao Junyu |
|
申请注册联系人电话: Applicant telephone: |
+86 152 8081 7501 |
研究负责人电话:
Study leader's |
+86 186 0591 3839 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
aijing0107@163.com |
研究负责人电子邮件: Study leader's E-mail: |
zjy0218@fjmu.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
福建省福州市台江区交通路88号 |
研究负责人通讯地址: |
福建省福州市闽侯县上街镇学府北路1号福建医科大学 |
|
Applicant address: |
No. 88 Jiaotong Road, Taijiang District, Fuzhou City, Fujian Province |
Study leader's address: |
Fujian Medical University, No.1 Xuefu North Road, Minhou County, Fuzhou City, Fujian Province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
福建医科大学 |
||
|
Applicant's institution: |
Fujian Medical University |
||
|
研究负责人所在单位: |
福建医科大学 |
||
|
Affiliation of the Leader: |
Fujian Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
福医伦理审字(2025)第170号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
福建医科大学生物医学研究伦理审查委员会 |
||
|
Name of the ethic committee: |
The Biomedical Research Ethics Review Committee of Fujian Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-03-20 00:00:00 | ||
|
伦理委员会联系人: |
张俊 |
||
|
Contact Name of the ethic committee: |
Zhang Jun |
||
|
伦理委员会联系地址: |
福建省福州市闽侯县上街镇学府北路1号福建医科大学 |
||
|
Contact Address of the ethic committee: |
Fujian Medical University, No.1 Xuefu North Road, Minhou County, Fuzhou City, Fujian Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 591 2286 2056 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
福建医科大学 |
||||||||||||||||||||||
|
Primary sponsor: |
Fujian Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
福建省福州市闽侯县上街镇学府北路1号福建医科大学 |
||||||||||||||||||||||
|
Primary sponsor's address: |
Fujian Medical University, No.1 Xuefu North Road, Minhou County, Fuzhou City, Fujian Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
福建医科大学 |
||||||||||||||||||||||
|
Source(s) of funding: |
Fujian Medical University |
||||||||||||||||||||||
|
研究疾病: |
无 |
||||||||||||||||||||||
|
Target disease: |
None |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
横断面 |
||||||||||||||||||||||
|
Study design: |
Cross-sectional |
||||||||||||||||||||||
|
研究目的: |
本研究拟系统分析睡眠障碍与认知障碍之间的双向关系,明确其关联机制及影响路径;识别轻度认知障碍伴随睡眠障碍老年人中的不同潜在亚群,控制心理社会因素的影响,分析各亚群体的关键影响因素;同时,建立认知功能与睡眠障碍的症状网络,揭示核心症状节点及其交互影响机制,为早期干预和精准治疗提供科学依据。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study aims to systematically analyze the bidirectional relationship between sleep disorders and cognitive impairment, elucidate the underlying mechanisms and pathways of their association, and identify distinct latent subgroups among older adults with mild cognitive impairment (MCI) and comorbid sleep disorders. By controlling for psychosocial factors, the study will explore key influencing factors within each subgroup. Additionally, a symptom network of cognitive function and sleep disorders will be constructed to identify core symptom nodes and their interactive mechanisms, providing a scientific basis for early intervention and precision treatment. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
①年龄≥60岁;②符合轻度认知障碍诊断标准(中国痴呆和认知障碍诊治指南MCI诊断标准‘):③符合睡眠障碍诊断标准(《中国成人失眠诊断与治疗指南》和国际睡眠障碍分类第3版(ICSD-3)的诊断标准);④视力和听力正常或仅轻微下降(如能通过佩戴助听设备等正常沟通交流),能够正常沟通交流;⑤所患慢性疾病(如高血压、糖尿病等)处于稳定状态。 |
||||||||||||||||||||||
|
Inclusion criteria |
1 Age >= 60 years; 2 Meets the diagnostic criteria for mild cognitive impairment (MCI) as defined by the Chinese Guidelines for the Diagnosis and Treatment of Dementia and Cognitive Disorders; 3 Meets the diagnostic criteria for sleep disorders based on the Chinese Guidelines for the Diagnosis and Treatment of Adult Insomnia and the International Classification of Sleep Disorders, 3rd Edition (ICSD-3); 4 Normal or only mildly impaired vision and hearing (e.g., able to communicate normally with assistive devices such as hearing aids); capable of effective communication; 5 Any chronic diseases (e.g., hypertension, diabetes) are in a stable condition. |
||||||||||||||||||||||
|
排除标准: |
①患有精神障碍、神经系统疾病、或其他可能影响认知的其他系统疾病(代谢性疾病、帕金森、甲亢等);②因严重疾病等原因无法完成神经心理测试;③已确诊为痴呆患者;④存在酒精依赖或药物滥用。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1 Presence of psychiatric disorders, neurological diseases, or other systemic conditions that may affect cognition (e.g., metabolic disorders, Parkinson’s disease, hyperthyroidism); 2 Inability to complete neuropsychological assessments due to severe illness or other reasons; 3 Diagnosed with dementia; 4 History of alcohol dependence or substance abuse. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-03-21 00:00:00至 To 2026-03-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2025-03-30 00:00:00 至 To 2025-10-15 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Not applicable |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
|
|
Blinding: |
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
国家生物信息中心 https://ngdc.cncb.ac.cn/gsub/ |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
China National center for Bioinformation (https://ngdc.cncb.ac.cn/gsub/) |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
不适用 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Not applicable |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |